← Browse by Condition
Medical Condition

extranodal nk t cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06824883 Phase 2
Recruiting

Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

Enrollment
49 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →